Literature DB >> 31465590

Recurrence of conjunctival goblet cells after discontinuation of dupilumab in a patient with dupilumab-related conjunctivitis.

A N Voorberg1, W F A den Dunnen2, R H J Wijdh3, M S de Bruin-Weller4, M L A Schuttelaar1.   

Abstract

Entities:  

Year:  2019        PMID： 31465590     DOI： 10.1111/jdv.15914

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN： 0926-9959            Impact factor:   6.166


× No keyword cloud information.
  3 in total

1.  Transient Increase in Circulating Basophils and Eosinophils in Dupilumab-associated Conjunctivitis in Patients with Atopic Dermatitis.

Authors:  Michie Katsuta; Yozo Ishiuji; Hiroyuki Matsuzaki; Ken-Ichi Yasuda; Budiman Kharma; Yoshimasa Nobeyama; Takaaki Hayashi; Yoshiki Tokura; Akihiko Asahina
Journal:  Acta Derm Venereol       Date:  2021-06-28       Impact factor: 3.875

2.  Dupilumab for the Treatment of Atopic Dermatitis in an Austrian Cohort-Real-Life Data Shows Rosacea-Like Folliculitis.

Authors:  Tamara Quint; Patrick M Brunner; Christoph Sinz; Irene Steiner; Robin Ristl; Kornelia Vigl; Susanne Kimeswenger; Katharina Neubauer; Detlev Pirkhammer; Martin Zikeli; Wolfram Hoetzenecker; Norbert Reider; Christine Bangert
Journal:  J Clin Med       Date:  2020-04-24       Impact factor: 4.241

Review 3.  Therapeutic New Era for Atopic Dermatitis: Part 1. Biologics.

Authors:  Jiyoung Ahn; Yusung Choi; Eric Lawrence Simpson
Journal:  Ann Dermatol       Date:  2020-12-30       Impact factor: 1.444
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.